ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Citalopram Axapharm:Axapharm AG
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
N06AB04 - CitalopramATC-DDD Version 2016. Source: WHO
N - Nervous System
 
N06 - Psychoanaleptics

This group comprises antidepressants, psychostimulants, nootropics anti-dementia drugs and combinations with psycholeptics.
Antiobesity preparations are classified in A08 - Antiobesity preparations, excl. diet products.

N06A - Antidepressants

This group comprises preparations used in the treatment of endogenous and exogenous depressions.
The group is subdivided mainly according to mode of action. The various antidepressants have different modes of action, and the classification will not reflect the exact mode of action of the various antidepressants.
Lithium, see N05AN - Lithium
Combination with psycholeptics, see N06C.

The DDDs are based on treatment of moderately severe depressions.

N06AB - Selective Serotonin Reuptake Inhibitors
 
N06AB04 - Citalopram
Concentr.Adm.RouteNote
20 mgO 
20 mgP 
2020 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home